Skip to main content
International Journal of Experimental Pathology logoLink to International Journal of Experimental Pathology
. 1990 Aug;71(4):507–511.

The effect of parenteral iron administration on the development of Staphylococcus aureus-induced experimental pyelonephritis in rats.

O Anğ 1, M Güngör 1, F Aricioğlu 1, D Inanç 1, H Sağduyu 1, V Uysal 1, M Küçüker 1
PMCID: PMC2002284  PMID: 2400738

Abstract

The first of the three groups of rats was taken as a control and the other two groups were injected with high (15 mg/kg) and low (5 mg/kg) doses of ferric ammonium citrate given intramuscularly twice daily for 5 days. Pyelonephritis was produced in all groups by intravenous inoculation with Staphylococcus aureus. Serum and urine of each rat was collected periodically and their iron content was determined. The severity of pyelonephritis was evaluated by determination of bacterial growth and pathological lesions in kidneys after 10 days of bacterial inoculation. The results showed that parenteral iron administration markedly aggravated pyelonephritis development in rats. But there was no significant difference in the severity of pyelonephritis between rats treated with high or low iron doses.

Full text

PDF
507

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bullen J. J. The significance of iron in infection. Rev Infect Dis. 1981 Nov-Dec;3(6):1127–1138. doi: 10.1093/clinids/3.6.1127. [DOI] [PubMed] [Google Scholar]
  2. Fletcher J., Goldstein E. The effect of parenteral iron preparations on experimental pyelonephritis. Br J Exp Pathol. 1970 Jun;51(3):280–285. [PMC free article] [PubMed] [Google Scholar]
  3. Güngör M., Anğ O., Inanç D., Petorak I., Koyuncuoğlu H. The effect of splenectomy on the development of experimental pyelonephritis. Experientia. 1981 Apr 15;37(4):387–389. doi: 10.1007/BF01959878. [DOI] [PubMed] [Google Scholar]
  4. Hart R. C., Kadis S., Chapman W. L., Jr Nutritional iron status and susceptibility to Proteus mirabilis pyelonephritis in the rat. Can J Microbiol. 1982 Jun;28(6):713–717. doi: 10.1139/m82-108. [DOI] [PubMed] [Google Scholar]
  5. Obek A., Anğ O., Petorak I., Iplikçi A., Büget E., Eroğlu L., Güngör M. Effects of a new sulfonamide combination on experimental pyelonephritis. Chemotherapy. 1973;19(3):171–178. doi: 10.1159/000221452. [DOI] [PubMed] [Google Scholar]
  6. Reddy S., Adcock K. J., Adeshina H., Cooke A. R., Akene J., McFAarlane H. Immunity, transferrin, and survival in kwashiorkor. Br Med J. 1970 Oct 31;4(5730):268–270. doi: 10.1136/bmj.4.5730.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. SCHADE A. L. SIGNIFICANCE OF SERUM IRON FOR THE GROWTH, BIOLOGICAL CHARACTERISTICS, AND METABOLISM OF STAPHYLOCOCCUS AUREUS. Biochem Z. 1963;338:140–148. [PubMed] [Google Scholar]
  8. Weinberg E. D. Iron withholding: a defense against infection and neoplasia. Physiol Rev. 1984 Jan;64(1):65–102. doi: 10.1152/physrev.1984.64.1.65. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES